Galectin-8 and -9 as prognostic factors for cervical cancer.
Susanne BeyerMaya WehrmannSarah MeisterTheresa M KolbenFabian TrillschAlexander BurgesBastian CzogallaElisa SchmoeckelSven MahnerUdo JeschkeThomas KolbenPublished in: Archives of gynecology and obstetrics (2022)
Our results suggest that expression of both galectins is inversely associated with tumor stage and progression. Gal-8 expression is associated with relapse-free survival of patients with SCC, while presence of Gal-9 in cervical cancer is associated with a better prognosis in regard of overall survival.